Scilex Holding Co

SCLXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$56.6M

▲ 21.1% YoY

Net Income

-$72.8M

▲ 36.3% YoY

EPS

$-0.61

▲ 52.3% YoY

Cash

$3.3M

▼ 16.6% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.